0.825
price up icon0.00%   0.00
after-market アフターアワーズ: .82 -0.005 -0.61%
loading
前日終値:
$0.825
開ける:
$0.825
24時間の取引高:
156.94K
Relative Volume:
0.70
時価総額:
$50.30M
収益:
-
当期純損益:
$-112.67M
株価収益率:
-0.4231
EPS:
-1.95
ネットキャッシュフロー:
$-79.26M
1週間 パフォーマンス:
-4.81%
1か月 パフォーマンス:
-15.82%
6か月 パフォーマンス:
-17.49%
1年 パフォーマンス:
-36.54%
1日の値動き範囲:
Value
$0.825
$0.8862
1週間の範囲:
Value
$0.82
$0.89
52週間の値動き範囲:
Value
$0.69
$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Name
名前
Kronos Bio Inc
Name
セクター
Healthcare (1164)
Name
電話
(650) 781-5200
Name
住所
1300 S. EL CAMINO REAL, SAN MATEO
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
KRON's Discussions on Twitter

KRON を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
KRON
Kronos Bio Inc
0.825 50.30M 0 -112.67M -79.26M -1.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-14 ダウングレード Piper Sandler Overweight → Neutral
2024-11-14 ダウングレード TD Cowen Buy → Hold
2022-09-14 開始されました Berenberg Buy
2021-10-20 再開されました Cowen Outperform
2021-06-24 開始されました H.C. Wainwright Buy
2020-11-03 開始されました Cowen Outperform
2020-11-03 開始されました Goldman Buy
2020-11-03 開始されました Jefferies Buy
2020-11-03 開始されました Piper Sandler Overweight
すべてを表示

Kronos Bio Inc (KRON) 最新ニュース

pulisher
Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025
pulisher
Mar 26, 2025

Kronos Bio Reports 2024 Financial Results - TipRanks

Mar 26, 2025
pulisher
Mar 25, 2025

Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 25, 2025
pulisher
Mar 20, 2025

Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023) - Yahoo Finance

Mar 20, 2025
pulisher
Mar 18, 2025

Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Kronos Bio earnings missed by $0.17, revenue fell short of estimates - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

Kronos Bio Inc (KRON) Q4 2024 Earnings: EPS Misses at -$0.43, Re - GuruFocus.com

Mar 18, 2025
pulisher
Mar 18, 2025

Kronos Bio, Inc. SEC 10-K Report - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

China Revives Its Carbon Credit Market: Price Swings & Future Outlook - The Globe and Mail

Mar 18, 2025
pulisher
Mar 18, 2025

Navigating the U.S. Planting Season with Enhanced Risk Management - The Globe and Mail

Mar 18, 2025
pulisher
Mar 18, 2025

Shootin' the Bull about cattle feeders - The Globe and Mail

Mar 18, 2025
pulisher
Mar 17, 2025

KRONOS BIO Earnings Preview: Recent $KRON Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025
pulisher
Mar 13, 2025

Kronos Bio (KRON) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Feb 23, 2025

Kronos Bio Insider Ups Holding By 36% During Year - Yahoo Finance

Feb 23, 2025
pulisher
Feb 17, 2025

Kronos Bio, Inc. (NASDAQ:KRON) Shares Sold by Partners Capital Investment Group LLP - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Peapod Lane Capital LLC Purchases New Position in Kronos Bio, Inc. (NASDAQ:KRON) - MarketBeat

Feb 16, 2025
pulisher
Jan 20, 2025

Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN

Jan 20, 2025
pulisher
Jan 19, 2025

Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat

Jan 19, 2025
pulisher
Jan 13, 2025

We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance

Jan 13, 2025
pulisher
Jan 11, 2025

Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World

Jan 11, 2025
pulisher
Jan 02, 2025

Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech

Jan 02, 2025
pulisher
Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World

Jan 01, 2025
pulisher
Jan 01, 2025

Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat

Jan 01, 2025
pulisher
Dec 28, 2024

Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia

Dec 28, 2024
pulisher
Dec 28, 2024

Kronos Bio ends partnership with Genentech - Investing.com India

Dec 28, 2024
pulisher
Dec 27, 2024

Kronos Bio Ends Collaboration with Genentech and Roche - TipRanks

Dec 27, 2024
pulisher
Dec 06, 2024

Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat

Dec 06, 2024
pulisher
Dec 03, 2024

Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE

Dec 03, 2024
pulisher
Dec 02, 2024

Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston

Dec 02, 2024
pulisher
Dec 01, 2024

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates - MSN

Dec 01, 2024
pulisher
Dec 01, 2024

KRON (Kronos Bio) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Kronos Bio Inc (KRON) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):